Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study Of The Effect Of Exemestane (Aromasin) Versus Placebo On Breast Density In Postmenopausal Women At Increased Risk For Development Of Breast Cancer

NCT00066586 is registered in ClinicalTrials.gov with NCIC Clinical Trials Group as lead sponsor.

NCT NCT00066586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00066586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study Of The Effect Of Exemestane (Aromasin) Versus Placebo On Breast Density In Postmenopausal Women At Increased Risk For Development Of Breast Cancer
Lead sponsor
NCIC Clinical Trials Group
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2001
Completion date
February 10, 2009
Enrollment
98 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer